hIL12RB1(5)

Nomenclature

C57BL/6JSmo-Il12rb1tm3(hIL12RB1)Smoc

Cat. NO.

NM-HU-251805

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Il12rb1

Model Description

The endogenous mouse Il12rb1 gene was replaced by human IL12RB1 gene.

Validation Data

image.png

Fig.1 Detection of IL12RB1 expression in thymus and spleen by RT-PCR. Mouse Il12rb1 mRNA (150 bp) was detectable only in WT C57BL/6 mice. Human IL12RB1 mRNA (193 bp) was detectable only in HO hIL12RB1(5) knockin mice but not in WT mice. Thymus and spleen RNA was extracted from 10-week-old male wild-type C57BL/6 (WT)(n=2) and homozygous hIL12RB1(5) knockin mice (HO) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. 

Abbr. M, marker; HO, homozygous; WT, wild type.

image.png

Fig.2 Detection of IL12RB1 expression in hIL12RB1(5) mice by WB. IL12RB1 was detectable in spleen from both WT C57BL/6 and HO hIL12RB1(5) mice, as the antibody was cross-reactived between human and mouse IL12RB1. The spleen tissue lysates were collected from 10-week-old male WT C57BL/6 mice and 10-week-old male HO hIL12RB1(5) mice, and then analyzed by western blot with anti-IL12RB1 antibody. 

Abbr. HO, homozygous; WT, wild type; PC, positive control, MCF-7 cells; M, marker.

image.png

Fig.3 Detection of IL12RB1 expression in hIL12RB1(5) mice by WB. IL12RB1 was detectable in spleen from both WT C57BL/6 and HO hIL12RB1(5) mice, as the antibody was cross-reactived between human and mouse IL12RB1. The spleen tissue lysates were collected from 10-week-old male WT C57BL/6 mice and 10-week-old male HO hIL12RB1(5) mice, and then analyzed by western blot with anti-IL12RB1 antibody (The antibody used is different from the one used in Fig.2)

Abbr. HO, homozygous; WT, wild type; PC, positive control, MCF-7 cells; M, marker.


You may also like

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more